Moderna

YTD

ALL

Trade Moderna 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About MRNA

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics.

CEO

Stéphane Bancel

CEOStéphane Bancel

Employees

5,800

Employees5,800

Headquarters

Cambridge, Massachusetts

HeadquartersCambridge, Massachusetts

Founded

2010

Founded2010

Employees

5,800

Employees5,800

MRNA Key Statistics

Market cap

10.46B

Market cap10.46B

Price-Earnings ratio

-3.04

Price-Earnings ratio-3.04

Dividend yield

—

Dividend yield—

Average volume

16.91M

Average volume16.91M

High today

$28.21

High today$28.21

Low today

$26.43

Low today$26.43

Open price

$26.92

Open price$26.92

Volume

12.91M

Volume12.91M

52 Week high

$158.82

52 Week high$158.82

52 Week low

$23.15

52 Week low$23.15

MRNA News

Sherwood News 11h

Moderna rises after FDA grants limited approval for next-gen Covid vaccine

Moderna CEO Stéphane Bancel said on Thursday that narrowing the eligibility while focusing on high-risk individuals could actually lead to more immunizations....

Seeking Alpha 3d

Moderna wins FDA nod for next-gen COVID-19 shot

Moderna (NASDAQ:MRNA) announced on Saturday that the U.S. Food and Drug Administration (FDA) approved its next-gen COVID-19 vaccine, mNEXSPIKE (mRNA-1283), maki...

Sherwood News 6d

RFK: Covid jab not recommended for healthy children, pregnant people

RFK: Covid jab not recommended for healthy children, pregnant people Health and Human Services Secretary Robert F. Kennedy Jr. said Tuesday that the COVID-19 s...

Analyst ratings

64%

of 28 ratings

Buy

21.4%

Hold

64.3%

Sell

14.3%

People also own

Based on the portfolios of people who own MRNA. This list is generated using Robinhood data, and it’s not a recommendation.